Royalty Pharma RPRX Ratios (2019-2026)

NASDAQ RPRX
$63.99 +0.11 (+0.17%)
As of: Sep 4, 2026 · 3:59 PM EDT
Reported Financials

Royalty Pharma Quarterly Ratios

Periods 29 quarters
Latest Jun 2026

Royalty Pharma reported a net margin of 12.09% for the quarter ended Jun 2026. These financial ratios cover 29 quarters of results from Jun 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Ratios Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Profitability
EBT Margin
37.86%9.32%22.79%91.72%38.44%-107.83%74.43%65.28%22.76%120.39%-0.75%36.18%142.80%56.32%76.45%16.01%72.91%57.22%74.26%12.09%
EBIT Margin
51.74%26.65%39.09%70.49%33.52%-85.31%70.03%46.24%28.24%102.82%-12.99%50.19%130.17%60.90%94.01%36.26%70.11%62.44%89.29%19.75%
EBITDA Margin
51.74%26.65%39.09%70.49%33.52%-85.31%70.03%46.24%28.24%102.82%-12.99%50.19%130.17%60.90%94.01%36.26%70.11%62.44%89.29%19.75%
Operating Margin
51.74%26.65%39.09%70.49%33.52%-85.31%70.03%46.24%28.24%102.82%-12.99%50.19%130.17%60.90%94.01%36.26%70.11%62.44%89.29%19.75%
Net Margin
37.86%9.32%22.79%91.72%38.44%-107.83%74.43%65.28%22.76%120.39%-0.75%36.18%142.80%56.32%76.45%16.01%72.91%57.22%74.26%12.09%
FCF Margin
-147.88%55.28%81.88%74.62%-135.58%56.51%63.18%101.70%22.82%-38.52%101.86%-13.11%-86.94%41.46%104.71%62.71%-42.55%15.03%42.16%70.82%
Efficiency
Assets AverageAssets Avg.
17.12B17.62B17.45B17.56B17.71B17.24B16.94B17.10B16.49B16.12B16.26B16.89B17.85B18.13B17.92B17.97B18.84B19.48B19.72B19.82B
Invested CapitalInvested Cap.
17.60B17.45B17.36B17.63B18.63B17.73B18.04B17.94B15.72B16.22B16.00B17.35B18.86B18.95B18.39B18.50B18.95B19.05B19.27B19.13B
Asset Utilization RatioAsset Util.
0.130.130.130.130.130.130.140.140.140.150.140.130.130.120.130.130.120.120.120.13
Leverage & Solvency
Interest Coverage RatioInterest Cover
6.843.274.678.044.09-10.2810.205.303.2912.97-1.675.5011.055.508.193.065.374.126.011.42
Debt Ratio
0.410.410.420.410.460.490.480.470.390.370.380.430.480.470.490.490.480.480.470.47
Times Interest Earned
6.843.274.678.044.09-10.2810.205.303.2912.97-1.675.5011.055.508.193.065.374.126.011.42
Dividends & Payouts
Dividend Coverage RatioDiv. Cover
1.77-0.233.7113.005.71-18.4015.2411.513.9229.30-0.136.3426.0010.638.072.4012.968.7311.742.36
FCF Payout RatioFCF Cover
-0.14-0.720.080.09-0.050.100.080.060.25-0.110.06-0.44-0.060.130.090.11-0.130.440.150.07
Dividend YieldDiv. Yield
0.57%-0.95%0.15%0.15%0.16%0.14%0.15%0.17%0.19%0.15%0.18%0.20%0.19%0.21%0.31%0.18%0.17%0.18%0.14%0.11%
Payout Ratio
0.57-4.290.270.080.18-0.050.070.090.250.03-7.490.160.040.090.120.420.080.110.090.42
Valuation
Price to EarningsP/E
98.93450.82184.6951.93110.69-39.3442.9852.66133.0323.39-0.00B80.6420.6744.9540.59226.8245.9962.6559.03395.65
Price to SalesP/S
37.4642.0342.0947.6342.5542.4231.9934.3730.2828.1531.9529.1729.5225.3231.0336.3133.5335.8543.8347.82
Price to BookP/B
2.112.362.332.452.342.522.231.891.691.661.841.611.621.451.802.212.122.302.783.29
Enterprise Value
24.49B26.54B25.74B27.44B27.26B26.16B23.77B19.85B18.74B19.84B20.64B17.15B19.06B17.44B19.63B23.52B22.68B24.90B30.08B34.36B
EV to EBIT
80.81173.03117.1772.62141.83-54.2049.6279.79123.7732.38-279.7263.5925.9348.2336.76112.1153.0964.1153.42258.09
EV to EBITDA
80.81173.03117.1772.62141.83-54.2049.6279.79123.7732.38-279.7263.5925.9348.2336.76112.1153.0964.1153.42258.09
Market Capitalization
21.94B24.20B23.66B25.53B24.40B24.00B21.88B18.50B16.24B16.78B18.14B15.67B16.67B15.03B17.63B21.01B20.43B22.30B27.64B32.24B
Price to FCFP/FCF
-25.3376.0351.4063.83-31.3875.0650.6333.80132.70-73.0931.36-222.58-33.9561.0629.6457.90-78.79238.59103.9667.53
EV to FCF
-28.2783.4255.9468.60-35.0681.8355.0036.27153.16-86.4335.67-243.49-38.8270.8533.0064.82-87.48266.42113.1471.96
EV to CFO
52.1354.1855.9347.7250.5945.9022.9932.6632.6825.6831.0526.0527.0923.4832.9464.6232.2830.1041.8847.16
Return Ratios
Return on Sales [ROS]ROS
51.74%26.65%39.09%70.49%33.52%-85.31%70.03%46.24%28.24%102.82%-12.99%50.19%130.17%60.90%94.01%36.26%70.11%62.44%89.29%19.75%
Return on Capital Employed [ROCE]ROCE
9.43%8.20%8.21%6.07%5.69%1.91%3.58%2.75%2.42%9.35%5.82%5.78%9.25%7.66%11.36%10.98%8.37%8.27%8.28%7.88%
Return on Assets [ROA]ROA
9.08%7.04%6.94%5.10%5.05%1.33%3.61%2.75%2.26%10.55%7.30%6.10%9.60%7.34%9.88%9.28%6.93%6.81%6.90%6.81%